Cost-effectiveness considerations in otitis media treatment.
about
Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in childrenOral or topical nasal steroids for hearing loss associated with otitis media with effusion in childrenNonencapsulated Streptococcus pneumoniae: Emergence and PathogenesisPrevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age.A genome-wide association study of chronic otitis media with effusion and recurrent otitis media identifies a novel susceptibility locus on chromosome 2In vivo capsular switch in Streptococcus pneumoniae--analysis by whole genome sequencing.New paradigms in the pathogenesis of otitis media in childrenGenetic contributors to otitis media: agnostic discovery approaches.Spiral ligament fibrocyte-derived MCP-1/CCL2 contributes to inner ear inflammation secondary to nontypeable H. influenzae-induced otitis media.Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis mediaOtitis media: a genome-wide linkage scan with evidence of susceptibility loci within the 17q12 and 10q22.3 regions.Clinical diagnostic accuracy of otitis media with effusion in children, and significance of myringotomy: diagnostic or therapeutic?Changing patterns of bacterial strains in adults and children with otitis media in korean tertiary care centersOtolaryngologists' perceptions of the indications for tympanostomy tube insertion in childrenThe Prevalence Rate of Helicobacter pylori Infection in, Chronic Otitis Media With Effusion Patients.Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillinCYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.Cost-effectiveness analysis of treatment options for acute otitis media.Mucosal immunization against respiratory bacterial pathogens.Histidine auxotrophy in commensal and disease-causing nontypeable Haemophilus influenzae.Which outcome measures are reported by clinical trials investigating OME treatment? A case for standardised reporting.Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.Referral of children with otitis media. Do family physicians and pediatricians agree?Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenomeSubinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilmsEmerging therapies for the treatment and prevention of otitis media.Acute Otitis Media and Other Complications of Viral Respiratory Infection.Risk factors for otitis media and carriage of multiple strains of Haemophilus influenzae and Streptococcus pneumoniae.Viral upper respiratory tract infection and otitis media complication in young children.Differential regulation of Streptococcus pneumoniae-induced human MUC5AC mucin expression through distinct MAPK pathways.Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials.Genetic susceptibility to chronic otitis media with effusion: candidate gene single nucleotide polymorphisms.Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections.Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media.A model-based cost-effectiveness analysis of a grommets-led care pathway for children with cleft palate affected by otitis media with effusion.Systemic inflammatory responses in children with acute otitis media due to Streptococcus pneumoniae and the impact of treatment with clarithromycin.Effectiveness of intratympanic dexamethasone in otitis media with effusion resistant to conventional therapy.Incremental health care utilization and costs for acute otitis media in children.Variation in costs among surgeons and hospitals in Pediatric tympanostomy tube placement.
P2860
Q24234572-A6478BE2-A883-4D34-B5DC-38026DDD4100Q24245568-D8C13373-2E37-4D07-98FB-A2C91272A53EQ26752517-8CDD5834-A659-4B6D-8B98-6564F4CD6E0EQ30366022-57CCCAF0-33C9-4577-ABD4-2121355AE796Q30409304-92AB7413-EA27-499F-9819-B6851E0BD1E3Q30423476-B3072079-E494-4BAC-85F2-D2800E5CD7D4Q30444709-3153B3A3-4B68-409C-9654-A542421E8CE8Q30457300-01AC5C32-70FD-4853-9216-8C1C481A8978Q30478615-43C67BF9-97D7-4C2E-BEA3-A1CA520C45FDQ33374661-E4C04A91-A680-4285-9E6C-4C910E9C1E74Q33499874-EC40ECE2-6094-467D-A2A9-4F825CC52E79Q33629748-E607AC9E-9C73-4A12-B16D-2E66E52917B5Q33728764-36DD22AF-7584-4E74-B704-922B121C2708Q34037686-ED19E058-D435-4CFA-96FB-1FA3E123680BQ34068652-5C0C00EA-67C7-4F80-880B-6FC5435DFF35Q34169314-63DE239A-63B5-4399-AEC2-3288EC87E241Q35412516-B09548A4-2452-4676-8978-78BE2D872E81Q35613757-F6E86586-9F26-4E87-8F2A-748D2E07E99DQ35623339-B68E8A18-D079-4468-A535-2061DF7D60F3Q35949354-6A58C0D8-9F36-4203-8451-54121CF8848BQ36040734-947D6AE9-1BF7-4330-AA15-F7C40A46B5D9Q36080545-744084C3-C050-4613-BC65-B558B93892FDQ36282743-9BC98171-34EA-4F4B-8888-EB7ABBAF3F95Q36314754-D8069065-67DC-4FE0-8AEF-14FCCB13A1ACQ36422690-A6D4B7C7-8DA3-44BA-A5A7-98924AA4FD5FQ36458405-5D5AC362-A4E1-406D-A755-15DC44B7C621Q36738373-F450447C-8E34-4C27-87A4-9E736A05C1A5Q37094044-41CE48E4-8BC9-467B-8716-C0728DE940FEQ37347741-04910E3E-6806-4A79-8BC5-04192D47E267Q37418949-7186B6CA-5BB2-4F8D-8113-50E29FF1DB3DQ37489215-3EB8BA48-A29A-4703-BE1F-B9CEAF6D8521Q37676182-09159B5C-32AF-41F0-92D2-C96DF1DF74EDQ37728927-0F75F831-1172-446F-838A-78D3FA724E1EQ37830688-DC9EE4BA-F8B8-4D7A-A4DB-41BF51350F3CQ38424720-FD55B832-8307-487A-A14A-D8DC04A904CEQ39179374-7BEBEF5A-6739-4C3B-9A6A-FEA6AF71FB96Q39785699-30366A6A-8191-4261-BA8D-656EC16E0620Q41867354-CA11F967-AF2C-4B30-BE71-5378176EA3B7Q45896446-7B9E7FEC-F559-4702-B450-A3B4BF22D9C3Q47624203-66E66440-6279-416F-9C17-3BDB23163187
P2860
Cost-effectiveness considerations in otitis media treatment.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Cost-effectiveness considerations in otitis media treatment.
@en
Cost-effectiveness considerations in otitis media treatment.
@nl
type
label
Cost-effectiveness considerations in otitis media treatment.
@en
Cost-effectiveness considerations in otitis media treatment.
@nl
prefLabel
Cost-effectiveness considerations in otitis media treatment.
@en
Cost-effectiveness considerations in otitis media treatment.
@nl
P1476
Cost-effectiveness considerations in otitis media treatment.
@en
P2093
P304
P356
10.1016/S0194-5998(96)70243-7
P577
1996-04-01T00:00:00Z